Satellos Bioscience Inc. (MSCL) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.121x

Based on the latest financial reports, Satellos Bioscience Inc. (MSCL) has a cash flow conversion efficiency ratio of -0.121x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-4.13 Million ≈ $-2.98 Million USD) by net assets (CA$34.00 Million ≈ $24.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Satellos Bioscience Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Satellos Bioscience Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Satellos Bioscience Inc. (MSCL) total liabilities for a breakdown of total debt and financial obligations.

Satellos Bioscience Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Satellos Bioscience Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
IRM ENERGY LTD NSE:IRMENERGY	0.020x
Horizon Gold Ltd AU:HRN	-0.016x
Ilyang Pharm KO:007570	0.009x
Donga Geologic KO:028100	0.014x
Bisalloy Steel Group Ltd AU:BIS	0.134x
Bank Jabar JK:BJBR	-0.231x
MAX Automation SE XETRA:MXHN	0.111x
Fountaine Pajo PA:ALFPC	-0.038x

Annual Cash Flow Conversion Efficiency for Satellos Bioscience Inc. (2019–2024)

The table below shows the annual cash flow conversion efficiency of Satellos Bioscience Inc. from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Satellos Bioscience Inc..

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$67.86 Million ≈ $49.09 Million	CA$-24.98 Million ≈ $-18.07 Million	-0.368x	-3.83%
2023-12-31	CA$40.67 Million ≈ $29.42 Million	CA$-14.42 Million ≈ $-10.43 Million	-0.354x	+79.35%
2022-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-5.78 Million ≈ $-4.18 Million	-1.717x	-257.45%
2021-12-31	CA$10.48 Million ≈ $7.58 Million	CA$-5.03 Million ≈ $-3.64 Million	-0.480x	-105.32%
2020-12-31	CA$-183.84K ≈ $-132.98K	CA$-1.66 Million ≈ $-1.20 Million	9.030x	+291.71%
2019-12-31	CA$408.57K ≈ $295.56K	CA$-1.92 Million ≈ $-1.39 Million	-4.710x	--

About Satellos Bioscience Inc.

TO:MSCL Canada Biotechnology

Market Cap

$158.46 Million

CA$219.06 Million CAD

Market Cap Rank

#17415 Global

#556 in Canada

Share Price

CA$10.62

Change (1 day)

-1.21%

52-Week Range

CA$0.52 - CA$17.85

All Time High

CA$17.85